What they were paid
OCULAR THERAPEUTIX Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $55,000 | $123,480 | $270,199 | $0 | $448,679 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: OCULAR THERAPEUTIX, INC DEF 14A filed April 30, 2026, accession 0001104659-26-053176, and prior-year filings. Open the filing on EDGAR.
Committees
FY2025 · as the proxy prints themNominating/Governance
The rest of the OCULAR THERAPEUTIX board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Adrienne L. Graves, Ph.D | Independent Director | $448,679 |
| Charles Warden | Lead Independent Director | $498,679 |
| Leslie J. Williams | Independent Director | $461,179 |
| Merilee Raines | Independent Director | $463,679 |
| Pravin U. Dugel, M.D | Chair of the Board | $0 |
| Richard L. Lindstrom, M.D | Independent Director | $461,179 |
The full OCULAR THERAPEUTIX compensation record
free company briefThis page is one director within OCULAR THERAPEUTIX's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat